Federal Register / Vol. 75, No. 164 / Wednesday, August 25, 2010 / Notices 52355 

of smoking intentions in predicting future 

smoking among youth: findings from the 

Monitoring the Future data,’’ Addiction 2004 

Jul; 99(7): 914–22; Pierce J, et al., ‘‘Validation 

of susceptibility as a predictor of which 

adolescents take up smoking in the United 

States,’’ Health Psychology, 1996(Sept): 355– 

61. 

Dated: August 20, 2010. 

David Dorsey, 

Acting Deputy Commissioner for Policy, 

Planning and Budget. 

[FR Doc. 2010–21123 Filed 8–24–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number NIOSH–210] 

A Review of Information Published 

Since 1995 on Coal Mine Dust 

Exposures and Associated Health 

Outcomes 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of draft document 

available for public comment. 

SUMMARY: The National Institute for 

Occupational Safety and Health of the 

Centers for Disease Control and 

Prevention announces the availability of 

a draft Current Intelligence Bulletin 

entitled ‘‘A Review of Information 

Published Since 1995 on Coal Mine 

Dust Exposures and Associated Health 

Outcomes’’ now available for public 

comment. The draft document and 

instructions for submitting comments 

can be found at: http://www.cdc.gov/ 

niosh/docket/review/docket210/ 

default.html. This document updates 

and supports the coal mine dust 

Recommended Exposure Limit (REL) of 

1 mg/m3 that was recommended in the 

1995 document, ‘‘Criteria for a 

Recommended Standard: Occupational 

Exposure to Respirable Coal Mine Dust, 

(1995–106)’’ which can be viewed at: 

http://www.cdc.gov/niosh/95-106.html. 

This guidance does not have the force 

and effect of the law. 

Public Comment Period: Comments 

must be received by September 24, 

2010. 

ADDRESSES: Written comments may be 

submitted to the NIOSH Docket Office, 

identified by Docket Number NIOSH– 

210, by any of the following methods: 

• Mail: NIOSH Docket Office, Robert 

A. Taft Laboratories, MS–C34, 4676 

Columbia Parkway, Cincinnati, Ohio 

45226. 

• Facsimile: (513) 533–8285. 

• E-mail: nioshdocket@cdc.gov. 

All information received in response 

to this notice will be available for public 

examination and copying at the NIOSH 

Docket Office, 4676 Columbia Parkway, 

Room 111, Cincinnati, Ohio 45226. A 

complete electronic docket containing 

all comments submitted will be 

available on the NIOSH Web page at 

http://www.cdc.gov/niosh/docket, and 

comments will be available in writing 

by request. NIOSH includes all 

comments received without change in 

the docket, including any personal 

information provided. All electronic 

comments should be formatted as 

Microsoft Word. Please make reference 

to Docket Number NIOSH- 210. 

FOR FUTHER INFORMATION CONTACT: 

Michael D. Attfield, Ph.D., telephone 

(304) 285–5737, e-mail mda1@cdc.gov 

or Eileen Storey, M.D., telephone (304) 

285–6382, e-mail eps4@cdc.gov, NIOSH, 

1095 Willowdale Road, Morgantown, 

WV 26505. 

Dated: August 17, 2010. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2010–21187 Filed 8–24–10; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Draft National Conversation on Public 

Health and Chemical Exposures Work 

Group Reports; Opportunity for Public 

Comment 

AGENCY: Centers for Disease Control and 

Prevention and Agency for Toxic 

Substances and Disease Registry (CDC/ 

ATSDR), Department of Health and 

Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The National Conversation on 

Public Health and Chemical Exposures 

is a collaborative initiative through 

which many organizations and 

individuals are helping develop an 

action agenda for strengthening the 

nation’s approach to protecting the 

public’s health from harmful chemical 

exposures. This notice announces the 

availability of draft National 

Conversation work group reports for 

public review and comment. CDC/ 

ATSDR has partnered with RESOLVE, a 

non-profit independent consensusbuilding organization, to manage 

aspects of the National Conversation 

project. RESOLVE is convening the 

National Conversation Leadership 

Council and facilitating the work group 

process. 

DATES: Draft work group reports will be 

available on or about September 7, 2010. 

In order to be considered, comments 

must be received within 14 days of the 

reports being posted. The public 

comment period is anticipated to close 

September 20, 2010. Comments received 

after the close of the comment period 

will be considered to the fullest extent 

possible. 

ADDRESSES: Draft work group reports 

will be available on RESOLVE’s Web 

site at http://www.resolv.org/ 

nationalconversation. Those interested 

in submitting comments are encouraged 

to submit them through that Web site. 

Comments can also be submitted by email to nccomments@resolv.org. Please 

indicate in the e-mail subject line the 

name of the work group report that your 

comments address (e.g. ‘‘Comments on 

Monitoring Work Group Report’’). 

Comments can be submitted by mail to 

National Conversation c/o RESOLVE, 

Inc. 1255 23rd Street, NW., Suite 875, 

Washington, DC 20037 or by fax 

attention to Jason Gershowitz at 

202–338–1264. 

FOR FURTHER INFORMATION CONTACT: 

Please direct questions about the 

National Conversation project to CDC/ 

ATSDR by e-mail at 

nationalconversation@cdc.gov, phone at 

770–488–0604, or mail at National 

Conversation, CDC/ATSDR, 4770 

Buford Hwy, NE., MS F–61, Atlanta, GA 

30341. 

SUPPLEMENTARY INFORMATION: The 

National Conversation project includes 

a Leadership Council, which will author 

the action agenda, and six work groups, 

formed to research and make 

recommendations on the following 

cross-cutting public health and 

chemical exposures issues: 

• Monitoring 

• Scientific Understanding 

• Policies and Practices 

• Chemical Emergencies 

• Serving Communities 

• Education and Communication 

Following the public comment 

period, National Conversation work 

groups will finalize their reports during 

the fall of 2010. The National 

Conversation Leadership Council will 

draw on work group reports and the 

results of public input received through 

Web dialogues, community 

conversations, and stakeholder forums 


srobinson on DSKHWCL6B1PROD with NOTICES
52356 Federal Register / Vol. 75, No. 164 / Wednesday, August 25, 2010 / Notices 

in authoring the action agenda. The 

Leadership Council’s draft action 

agenda is anticipated to be available for 

public review and comment in 

December 2010. Work group reports will 

be appended to the action agenda. 

For more information on National 

Conversation work groups, including 

their charges and meeting summaries, 

visit this Web site: http:// 

www.atsdr.cdc.gov/ 

nationalconversation/ 

work_groups.html. 

For additional information on the 

National Conversation on Public Health 

and Chemical Exposures, visit this Web 

site: http://www.atsdr.cdc.gov/ 

nationalconversation/. 

Dated: August 18, 2010. 

Tanja Popovic, 

Deputy Associate Director for Science Centers 

for Disease Control and Prevention. 

[FR Doc. 2010–21120 Filed 8–24–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: National Human 

Immunodeficiency Virus (HIV) 

Behavioral Surveillance, Funding 

Opportunity Announcement PS11–001; 

Initial Review 

Correction: This notice was published 

in the Federal Register on August 4, 

2010, Volume 75, Number 149, page 

46952. The time and date should read 

as follows: 

Time and Date: 8 a.m.–5 p.m., 

October 4, 2010 (Closed). 

Contact Person for More Information: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, 1600 

Clifton Road, NE., Mailstop E60, 

Atlanta, GA 30333, Telephone: (404) 

498–2293. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: August 18, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. C1–2010–21185 Filed 8–24–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Diabetes 

Immunology Ancillary Studies. 

Date: October 7, 2010. 

Time: 2:30 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892. (Telephone 

Conference Call) 

Contact Person: D.G. Patel, PhD, Scientific 

Review Officer, Review Branch, DEA, 

NIDDK, National Institutes of Health, Room 

756, 6707 Democracy Boulevard, Bethesda 

MD 20892–5452, (301) 594–7682, 

pateldg@niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Diabetes 

Epidemiology Ancillary Study. 

Date: October 13, 2010. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda MD 20892. (Telephone 

Conference Call) 

Contact Person: D.G. Patel, PhD, Scientific 

Review Officer, Review Branch, DEA, 

NIDDK, National Institutes of Health, Room 

756, 6707 Democracy Boulevard, Bethesda, 

MD 20892–5452, (301) 594–7682, 

pateldg@niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Review of R24 

Applications. 

Date: October 27, 2010. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: D.G. Patel, PhD, Scientific 

Review Officer, Review Branch, DEA, 

NIDDK, National Institutes of Health, Room 

756, 6707 Democracy Boulevard, Bethesda, 

MD 20892–5452, (301) 594–7682, 

pateldg@niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: August 19, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–21090 Filed 8–24–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Cardioprotection, Remodeling and 

Collateral Circulation. 

Date: September 8–9, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting.) 

Contact Person: Lawrence E. Boerboom, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4130, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

8367, boerboom@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Reproduction and Metabolism. 

Date: September 29–30, 2010. 

Time: 11 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 


srobinson on DSKHWCL6B1PROD with NOTICES